Puma Gross Profit vs Income Before Tax Analysis
PBYI Stock | USD 4.94 0.20 3.89% |
Puma Biotechnology financial indicator trend analysis is much more than just breaking down Puma Biotechnology prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Puma Biotechnology is a good investment. Please check the relationship between Puma Biotechnology Gross Profit and its Income Before Tax accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.
Gross Profit vs Income Before Tax
Gross Profit vs Income Before Tax Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Puma Biotechnology Gross Profit account and Income Before Tax. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Puma Biotechnology's Gross Profit and Income Before Tax is 0.4. Overlapping area represents the amount of variation of Gross Profit that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Puma Biotechnology, assuming nothing else is changed. The correlation between historical values of Puma Biotechnology's Gross Profit and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Gross Profit of Puma Biotechnology are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Gross Profit i.e., Puma Biotechnology's Gross Profit and Income Before Tax go up and down completely randomly.
Correlation Coefficient | 0.4 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Gross Profit
Gross profit is a required income statement account that reflects total revenue of Puma Biotechnology minus its cost of goods sold. It is profit before Puma Biotechnology operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Income Before Tax
Income Before Tax which can also be referred as pre-tax income is reported on Puma Biotechnology income statement and is an important metric when analyzing Puma Biotechnology profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.Most indicators from Puma Biotechnology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Puma Biotechnology current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.As of now, Puma Biotechnology's Issuance Of Capital Stock is increasing as compared to previous years. The Puma Biotechnology's current Enterprise Value Over EBITDA is estimated to increase to 5.42, while Selling General Administrative is projected to decrease to under 65.7 M.
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 10.6M | 8.9M | 10.2M | 9.1M | Interest Income | 160K | 813K | 2.4M | 1.5M |
Puma Biotechnology fundamental ratios Correlations
Click cells to compare fundamentals
Puma Biotechnology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Puma Biotechnology fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 234.9M | 244.2M | 226.6M | 222.1M | 230.5M | 165.1M | |
Total Stockholder Equity | 17.5M | (6M) | (2.4M) | 21.6M | 53.4M | 63.0M | |
Net Debt | 60.2M | 35.7M | 53.5M | 38.1M | 26.9M | 28.3M | |
Cash | 60M | 85.3M | 63.1M | 76.2M | 84.6M | 68.5M | |
Cash And Short Term Investments | 60M | 85.3M | 63.1M | 76.2M | 95.9M | 71.9M | |
Common Stock Shares Outstanding | 38.8M | 39.6M | 40.6M | 44.9M | 47.6M | 32.7M | |
Liabilities And Stockholders Equity | 234.9M | 244.2M | 226.6M | 222.1M | 230.5M | 165.1M | |
Other Stockholder Equity | 1.3B | 1.3B | 1.4B | 1.4B | 1.4B | 762.9M | |
Total Liab | 217.4M | 250.2M | 229.0M | 200.5M | 177.1M | 108.6M | |
Total Current Assets | 166.3M | 146.1M | 140.0M | 134.3M | 156.2M | 127.0M | |
Total Current Liabilities | 90.8M | 114.3M | 109.6M | 77.5M | 99.4M | 56.7M | |
Retained Earnings | (1.3B) | (1.3B) | (1.4B) | (1.4B) | (1.3B) | (1.3B) | |
Accounts Payable | 19.2M | 12.1M | 11.2M | 6.4M | 6.9M | 12.3M | |
Other Current Liab | 69.0M | 2.5M | 2.3M | 66.9M | 53.7M | 30.7M | |
Other Liab | 9M | 32.3M | 6.4M | 12.8M | 14.7M | 7.6M | |
Net Tangible Assets | (23.0M) | (80.1M) | (68.6M) | 21.6M | 19.4M | 18.5M | |
Property Plant And Equipment Net | 21.8M | 18.9M | 15.8M | 12.5M | 8.6M | 8.4M | |
Non Current Assets Total | 68.6M | 98.1M | 86.6M | 87.8M | 74.3M | 49.8M | |
Non Currrent Assets Other | 6.3M | 5.1M | 4.7M | 4.7M | 2.7M | 5.0M | |
Other Assets | 6.3M | 5.1M | 4.7M | 4.7M | 1.0 | 0.95 | |
Long Term Debt | 95.0M | 84.0M | 97.1M | 98.3M | 65.7M | 54.2M | |
Retained Earnings Total Equity | (1.3B) | (1.3B) | (1.4B) | (1.4B) | (1.2B) | (1.3B) | |
Short Term Investments | 51.6M | 8.1M | 19.0M | 4.9M | 11.4M | 10.8M | |
Non Current Liabilities Total | 126.6M | 135.9M | 119.4M | 123.0M | 77.7M | 68.1M | |
Capital Surpluse | 1.3B | 1.3B | 1.4B | 1.4B | 1.6B | 952.6M | |
Inventory | 3.2M | 3.5M | 7.1M | 4.5M | 7.1M | 8.2M | |
Other Current Assets | 2.7M | 2.7M | 2.6M | 2.0M | 4.7M | 4.8M | |
Deferred Long Term Liab | 5.8M | 868K | 955K | 743K | 854.5K | 811.7K | |
Property Plant And Equipment Gross | 21.8M | 18.9M | 22.6M | 1.1M | 16.3M | 8.7M | |
Accumulated Other Comprehensive Income | (12K) | 62K | 0.0 | (2K) | (4K) | (4.2K) | |
Intangible Assets | 40.5M | 74.1M | 66.1M | 70.6M | 60.9M | 34.3M | |
Property Plant Equipment | 3.3M | 2.5M | 15.8M | 1.1M | 1.3M | 1.3M | |
Net Receivables | 28.9M | 25.5M | 32.5M | 42.3M | 48.5M | 25.5M | |
Short Long Term Debt Total | 120.2M | 121.0M | 116.6M | 114.3M | 111.5M | 123.2M | |
Long Term Debt Total | 151.9M | 95.0M | 84.0M | 97.1M | 111.7M | 104.8M | |
Net Invested Capital | 112.4M | 92.4M | 94.6M | 119.9M | 153.1M | 135.2M | |
Net Working Capital | 75.5M | 31.9M | 30.4M | 56.8M | 56.8M | 49.8M |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Puma Biotechnology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Puma Biotechnology's short interest history, or implied volatility extrapolated from Puma Biotechnology options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Puma Biotechnology using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Complementary Tools for Puma Stock analysis
When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Transaction History View history of all your transactions and understand their impact on performance | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Puma Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.78) | Earnings Share 0.32 | Revenue Per Share 4.769 | Quarterly Revenue Growth (0.17) | Return On Assets 0.0919 |
The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.